ArkeaBio
PrivateLast Round
Series A
Extension
Sep 30, 2026
Total Funding Raised
$60.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
ArkeaBio is an agricultural biotechnology company developing a vaccine to reduce methane emissions from ruminant animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Carbon Capture
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArkeaBio Comparables
Compare ArkeaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lucidome Bio | 89% | |
| Pasture Biosciences | 87% | |
| Agteria Biotech | 80% |
ArkeaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 30, 2026 | ||||
| Series A Extension | Sep 23, 2025 | ||||
| Series A | May 8, 2024 | ||||
| Seed | Dec 12, 2022 |
Key People
Founding team and executive leadership
ArkeaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Overview Capital | Series A |
| Breakthrough Energy Ventures | Series A Extension, Seed, Series A |
| The Grantham Foundation for the Protection of the Environment | Series A |
| Lowercarbon Capital | Series A |
| Rabo Ventures | Series A |
| AgriZeroNZ | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 30, 2026
$15M round led by AgriZeroNZ.
- Jul 28, 2026
Monthly visitors increased 184% MoM, reaching 1.4K.
Recent news
Latest coverage and updates
- receives_financingOct 1, 2026
ArkeaBio Corp received $12M in Seed financing in 2022
- is_developingOct 1, 2026
ArkeaBio Corp, a Charlestown, Massachusetts agricultural-bioscience company, is developing a vaccine intended to reduce methane emissions from cattle.
- hiresSep 30, 2026
ArkeaBio Corp appoints Frank Wooten as CEO in Massachusetts in Sep '25
- receives_financingSep 29, 2026
ArkeaBio Corp raises $15M in Series A2 financing
- receives_financingSep 29, 2026
ArkeaBio Corp receives $15M in a Series A1 round in Massachusetts
ArkeaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ArkeaBio's valuation, stock price, and market status.
Is ArkeaBio a public or private company?
ArkeaBio is a private company.
What is the current stock price of ArkeaBio?
ArkeaBio is a private company, so its shares have no public market price. Caplight tracks ArkeaBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ArkeaBio worth (valuation)?
Valuation information for ArkeaBio is not publicly available.
Can I buy ArkeaBio stock?
ArkeaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ArkeaBio's last funding round?
ArkeaBio's most recent funding round was Series A Extension on September 30, 2026.
Who are the main investors in ArkeaBio?
Key investors in ArkeaBio include Breakthrough Energy Ventures, AgriZeroNZ.
Will ArkeaBio IPO soon?
No public IPO plans have been announced for ArkeaBio.
How can I track ArkeaBio secondary market activity?
Caplight tracks bids, offers, and trades in ArkeaBio's shares on secondary markets.